Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05954975
Other study ID # 132698
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date September 2023
Est. completion date May 2024

Study information

Verified date July 2023
Source Leiden University Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this prospective single center feasibility study is to assess the feasibility of using BabyCheck and PO by GPs as an illness severity score for young infants > 6 months of age in order to aid the decision for referral to hospital. The emergency GP posts in Leiderdorp will add the BabyCheck and PO to their standard evaluation of infants presenting with systemic illness < six months of age for a period of six months. The feasibility will be determined by calculating the percentage of eligible infants in whom a complete BabyCheck score and PO data were retrieved. The investigators consider the protocol feasible if this is done in 80% of all eligible infants.


Description:

Young infants frequently visit general practitioners (GP) with acute pathology, such as infections. Assessing severity of illness in this group is often challenging, since the likelihood of serious illness in this group is low, deterioration of the clinical condition can occur more rapidly. Therefore, early recognition of pathology in young babies is pivotal. The Netherlands Triage System (derived from the Manchester Triage System) is a reliable tool for both children and adults to decide if a patient should be seen by the GP. However, after presentation at the GP, a scoring system to assess illness severity in babies with a decision aid for referral to hospital, is currently lacking. The BabyCheck is a scoring system developed and validated as a clinical checklist to assess young infants up to six months of age. The BabyCheck is validated in multiple low illness prevalent settings. In addition, abnormal oxygen saturation and/or heart rate can be an early sign of infection, respiratory or circulatory pathology in infants. Since it is difficult to adequately judge oxygen saturation solely by skin colour, it is preferable to objectify this parameter via pulse oximetry (PO). The aim of this study is to assess the feasibility of using BabyCheck and PO by GPs as an illness severity score for young infants < six months of age in order to aid the decision for referral to hospital.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 1500
Est. completion date May 2024
Est. primary completion date March 2024
Accepts healthy volunteers No
Gender All
Age group 0 Months to 6 Months
Eligibility Inclusion Criteria: - Infants up to six months of age. - Presenting with systemic illness (no injuries or traumata). - Presenting at the emergency GP post of Leiderdorp. Exclusion Criteria: - Infants up to six months of age, presenting with traumata or that are in a resuscitation setting. - Infants with referral to other hospitals than the Alrijne hospital. The location for referral is coded and available from the anonymized database of the emergency GP post. - Infant < 1 month of age presenting with fever (body temperature > 38.0 °C), with or without unknown origin, since these infants should always be referred according to the national guidelines for GPs. - Infants < 3 months of age presenting with fever of unknown origin (temperature > 38.0 °C), since these infants should always be referred according to the national guidelines for GPs.

Study Design


Related Conditions & MeSH terms


Intervention

Combination Product:
BabyCheck and pulse oximetry
The BabyCheck is a validated scoring system to grade the severity of acute systemic illness in infants up to six months of age. Severity of illness is graded by using a weighted score of a combination of nineteen signs and symptoms. The higher the score, the higher the chance of severe illness. Nellcor PM10N is a pulse oximeter which is cleared for use in young infants. A sensor for infants will be used, so reliable oxygen saturation and heart rate can be obtained.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Ilona C Narayen, MD pHD

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility Feasibility will be determined by calculating the percentage of eligible infants in whom a complete BabyCheck score and PO data were retrieved. We consider the protocol feasible if this is done in 80% of all eligible infants. 6 months
Secondary Sensitivity and specificity of the combined BabyCheck-PO score a referral to the pediatric department is assigned just if no treatment, diagnostic tools or follow up is performed in hospital, which could not have been performed at the GP post. 6 months
Secondary Acceptability of GPs Was the combination of questions and pulse oximetry useful for assessing illness severity in this infant? [yes/no]
Did the outcome of the scores influence your decision for referral? [yes/no]
Do you have any comments for the reseaerchers? [open field]
6 months
Secondary Acceptability of pediatricians Was the referral necessary or just? [yes/no]
Was the referral possibly previously missed or too much delayed? [yes/no].
Was the combination of BabyCheck and pulse oximetry useful in assessing illness severity in this infant? [yes/no]
6 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05936112 - Quantification of Fecal Calprotectin Concentration Difference Between Infants Aged Under 4 Months Old Suffering From Functional Gastrointestinal Disorders (FGID) and Infants Aged Under 4 Months Old Free From Disorders : a Transversal Case-control Monocentric Study N/A
Completed NCT02968628 - Effect of Maternal Diabetes on Brain Development, as Measured by Neonatal Electroencephalogram (EEG)
Not yet recruiting NCT00994149 - Diazoxide In the Management Of Hypoglycemic Neonates Phase 2/Phase 3
Completed NCT03571932 - Assessment of Family Planning and Immunization Service Integration in Liberia
Completed NCT02865772 - Lamellar Body Counts on Gastric Aspirate in Healthy Term Newborns N/A
Completed NCT03535311 - Estimating Insertion Length of Umbilical Catheters in Newborn Infants
Completed NCT00477594 - Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia Phase 2
Recruiting NCT06139809 - Noninvasive Positive Pressure Ventilation During Neonatal Nasal Intubation N/A
Recruiting NCT03162653 - Effect of Allopurinol for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome Phase 3
Not yet recruiting NCT06267508 - Increasing Neonatal HIV Test and Treat to Maximize the Long-Term Impact on Infant Health and Novel Infant Antiretroviral Treatment
Completed NCT02701920 - HeartLight: Heart Rate Monitoring for Newborn Resuscitation
Completed NCT01124331 - Appropriate Oxygen Levels for Extremely Preterm Infants: a Prospective Meta-analysis N/A
Active, not recruiting NCT04354220 - Capnography Monitoring in Ventilated Children
Recruiting NCT05793723 - Long-term Respiratory Complications in Infants With Perinatal COVID-19
Completed NCT03404284 - Assessment of Family Planning and Immunization Service Integration in Malawi N/A
Completed NCT01954056 - Hydrocortisone for Term Hypotension Phase 3
Not yet recruiting NCT06255886 - Treatment of Gastroesophageal Reflux Disease in Infants Phase 4
Completed NCT02434380 - Effect of Vitamin D Replacement on Maternal and Neonatal Outcomes Phase 3
Completed NCT00607373 - Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia Phase 3
Completed NCT00362180 - Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration Phase 2